Impact of SARS-CoV-2 vaccination and passive prophylaxis with tixagevimab/cilgavimab on CAR-T patients: a three-year regional experience from the Italian covid pandemic

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2023-12, Vol.58 (12), p.1394-1396
Hauptverfasser:	Galli, Eugenio, Di Rocco, Alice, Pansini, Ilaria, Frondizi, Federico, Di Palma, Martina, Metafuni, Elisabetta, Piccirillo, Nicola, Bianchi, Maria, Cingolani, Antonella, Torelli, Giovanni Fernando, Hohaus, Stefan, Chiusolo, Patrizia, Iori, Anna Paola, Sica, Simona, Martelli, Maurizio, Sorà, Federica
Format:	Artikel
Sprache:	eng
Schlagworte:	692/308/174 692/699/1541/1990/291/1621/1915 692/700/565/251 Cell Biology Correspondence COVID-19 - prevention & control COVID-19 Vaccines Hematology Humans Internal Medicine Medicine Medicine & Public Health Pandemics Pandemics - prevention & control Prophylaxis Public Health Receptors, Chimeric Antigen SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Stem Cells Vaccination
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!